We are pleased to announce the second annual edition of the Pharmaceutical Crystallization Summit coming this October.

Crystallization technologies are bridges between drug substances (DS) and drug products (DP) enabling consistent and robust safety and efficacy profiles for small molecule-based medicines. In an effort to fully utilize existing tools and develop better methodologies for solving bottleneck problems, the summit will gather top industrial and academic experts to discuss their work related to DS crystallization R&D and manufacturing with a special focus on:

Areas of opportunity identified by Enabling Technologies Consortium (ETC)

• Crystal structure prediction
• Crystal shape prediction
• Solubility assessment
• Purification
• Analytical technologies

Areas of potential innovation identified by National Academies of Sciences, Engineering, and Medicine (NASEM)

• Co-processed APIs
• Process intensification
• Additive manufacturing
• Advanced process control & automation
• Modular systems

In compliance with the CDC and New Jersey Department of Health guidelines, we are happy to announce that this year’s summit will be proceeding as a hybrid (live and virtual) with the following educational sessions:

• Smarter Solid Form and Preformulation Studies
• Physical Property Based Crystallization Process Development
• Particle Engineering and DS-DP Co-Processing
• Panel Discussions and Poster Presentations

For more details, please visit: https://www.pharmaceuticalcrystallizationsummit.com/